Microengineered in vitro model of cardiac fibrosis through modulating myofibroblast mechanotransduction
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Cardiac fibrosis greatly impairs normal heart function post infarction and there is no effective anti-fibrotic drug developed at present. The current therapies for cardiac infarction mainly take effect by eliminating occlusion in coronary artery by thrombolysis drugs, vascular stent grafting or heart bypass operation, which are capable to provide sufficient blood flow for intact myocardium yet showed subtle efficacy in ameliorating fibrosis condition. The advances of in vitro cell/tissue models open new avenues for drug assessment due to the low cost, good controllability and availability as well as the convenience for operation as compared to the animal models. To our knowledge, no proper biomimetic in vitro cardiac fibrosis model has been reported yet. Here we engineered an in vitro cardiac fibrosis model using heart-derived fibroblasts, and the fibrogenesis was recapitulated by patterning the substrate rigidity which mimicked the mechanical heterogeneity of myocardium post-infarction. Various biomarkers for cardiac fibrosis were assayed to validate the biomimicry of the engineered platform. Subsequent addition of Rho-associated protein kinase (ROCK) pathway inhibitor reduced the ratio of myofibroblasts, indicating the feasibility of applying this platform in screening anti-fibrosis drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A majority of disease models of cardiac fibrosis are based on 2D coculture and thus lack the intricate microenvironmental properties of the fibrotic ECMs [306,307].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [306]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 53 · Cited by 54
Research works printed but not linked: 1
- Harber L C, 1982, J. Natl. Cancer Inst., 69, 237
Metadata
- Authors
- Zhao, H., Li, X., Zhao, S., Zeng, Y., Zhao, L., Ding, H., Sun, W., & Du, Y.
- Affiliations
- Tsinghua University (CN)
- Drexel University (US)
- Corresponding author
- Du, Yanan
- Venue
- Biofabrication
- Publisher
- IOP Publishing
- Published
- 2014-11-07
- Volume
- 6
- Issue
- 4
- Pages
- 045009
- ISSN
- 1758-5082 (ISSN-L)
- 1758-5090
- OpenAlex
- W2007963164
- Cited by
- 54
- References
- 53
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 5 · 2020: 5 · 2019: 5 · 2018: 3 · 2017: 7 · 2016: 5 · 2015: 5
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- iopscience.iop.org/info/page/text-and-data-mining (tdm)
- iopscience.iop.org/page/copyright (vor)
- Locations
- Biofabrication (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- myocardial fibrosis, fibrogenesis, Rho kinase, myocardial infarction, biomimetic tissue engineering, cardiac biomarkers
- MeSH terms
- Amides, Animals, Cardiovascular Agents, Cells, Cultured, Fibrosis, Heart Diseases, Male, Models, Cardiovascular, Pyridines, Rats, Sprague-Dawley, Mechanotransduction, Cellular, NIH 3T3 Cells, Cell Proliferation, Mice, Drug Discovery, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Microengineered in vitro model of cardiac fibrosis through modulating myofibroblast mechanotransduction. https://app.cochat.ai/papers/10.1088/1758-5082/6/4/045009
- The paper
- Zhao, H., Li, X., Zhao, S., Zeng, Y., Zhao, L., Ding, H., Sun, W., & Du, Y. (2014). Microengineered in vitro model of cardiac fibrosis through modulating myofibroblast mechanotransduction. Biofabrication. https://doi.org/10.1088/1758-5082/6/4/045009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.